Procurement
Teams
for New York

Through innovation,
we improve the transplant community

Learn More

T-Path® is HIPAA compliant, cloud based information, file and image sharing with AI applications for assisting pathological analysis.

AI Application
 LSQ:Liver Steatosis Quantification



 KDP:Kidney donor pathology AI assisting software



 Organ IQ:Assessing liver size, volume, and steatosis, and kidney size and volume.

Background

Organ Transplantation Challenges in the U.S. and PTNY®'s Innovative Solution

Transplant centers in the United States perform about 40,000 organ transplants annually.
Challenges persist in the evaluation of donor organs. Specifically, variability in pathological diagnosis, unavailability of expert transplant pathologist and difficulty of slide image and information sharing lead to the discarding of viable organs.

To address this critical issue, PTNY® has developed an AI-powered "Donor Biopsy Information Platform."

  • Provide consistent, accurate biopsy interpretations in real-time.
  • Support transplant centers in their decision-making.
  • Seamless information sharing among stakeholders.

This system has been operational at the Nevada Donor Network,
where it has received strong praise for its potential to reduce organ discard rates and OPO workload.

  • T-Path

    T-Path®

    Donor Biopsy Information Platform

    Read More
  • Liver AI

    Liver AI

    Liver Steatosis Quantification (LSQ)

    Read More
  • Kidney AI

    Kidney AI

    Kidney Donor Pathology Assessment (KDP) based on OPTN guidelines.

    Read More
  • DICOM Viewer

    DICOM Viewer

    DICOM images can be rapidly viewed and analyzed directly in a web browser, making it suitable for a wide range of uses including medical research, education, and clinical support.

    Read More
  • diagnosis

    Pathological Assessment

    Expert transplant pathologist service

    Read More
  • system

    System Construction
    Support Service

    Read More

News

  • July 3, 2026

    Banff Consensus Recommendations and Development of a HIPAA-Compliant, Cloud-Based Platform (T-Path) for Steatosis Assessment in Donor Liver Biopsies Using Artificial Intelligence — October 2026.

    Read More
  • June 29, 2026

    We have initiated a partnership with One Transplant Hub and Perfusalife.        We support the transplant community as a single, trusted partner.

    Read More
  • June 29, 2026

    “Liver steatosis quantification using artificial intelligence” has been accepted for a poster presentation at The Transplantation Society 2026 Congress (TTS 2026) in Sydney, Australia.

    Read More
View All News

Contact /
Request Experience

Contact / Request Experience